Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR-37.6%
5Y CAGR-27.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-37.6%/yr
Annual compound
5Y CAGR
-27.3%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 26.81% |
| 2024 | 105.97% |
| 2023 | -16.25% |
| 2022 | 110.53% |
| 2021 | -47.22% |
| 2020 | 132.26% |
| 2019 | 193.94% |
| 2018 | -57.14% |
| 2017 | 4.55% |
| 2016 | 12.00% |